[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming

R Mattioli, A Ilari, B Colotti, L Mosca, F Fazi… - Molecular Aspects of …, 2023 - Elsevier
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …

circRNA-miRNA-mRNA in breast cancer

M Zhang, X Bai, X Zeng, J Liu, F Liu, Z Zhang - Clinica Chimica Acta, 2021 - Elsevier
Among cancers, breast cancer has the highest incidence rate among women and poses a
tremendous threat to women's health. Messenger RNA (mRNA), microRNA (miRNA) and …

[HTML][HTML] Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis

AS Zangouei, M Zangoue, N Taghehchian… - Biological …, 2023 - SciELO Chile
Cell cycle is one of the main cellular mechanisms involved in tumor progression. Almost all
of the active molecular pathways in tumor cells directly or indirectly target the cell cycle …

Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy

MDA Paskeh, H Saebfar, MK Mahabady, S Orouei… - Life Sciences, 2022 - Elsevier
Gene therapy can be used as a cancer therapy by affecting signaling networks participating
in the aggressive behavior of tumors. Small interfering RNA (siRNA) is a genetic tool …

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers

F Tolue Ghasaban, A Maharati, AS Zangouei… - Cancer cell …, 2023 - Springer
Although, there is a high rate of good prognosis in early stage head and neck tumors, about
half of these tumors are detected in advanced stages with poor prognosis. A combination of …

PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression

N Taghehchian, A Maharati, I Akhlaghipour… - Cancer Cell …, 2023 - Springer
Surgery and chemo-radiotherapy are used as the common first-line treatment options in
many cancers. However, tumor relapse is observed in many cancer patients following such …

MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells

F Tolue Ghasaban, A Maharati, I Akhlaghipour… - Cancer Cell …, 2023 - Springer
Chemotherapy is one of the most common therapeutic methods in advanced and metastatic
tumors. Cisplatin (CDDP) is considered as one of the main first-line chemotherapy drugs in …

MicroRNAs as the critical regulators of forkhead box protein family in pancreatic, thyroid, and liver cancers

I Akhlaghipour, A Fanoodi, AS Zangouei… - Biochemical …, 2023 - Springer
The metabolism of human body is mainly regulated by the pancreas, liver, and thyroid using
the hormones or exocrine secretions that affect the metabolic processes from food digestion …

MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells

A Maharati, AS Zanguei, G Khalili-Tanha… - Cell Communication and …, 2022 - Springer
Lung cancer is the second most common and the leading cause of cancer related deaths
globally. Tyrosine Kinase Inhibitors (TKIs) are among the common therapeutic strategies in …

Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells

OE Abdel-Sattar, RM Allam, AM Al-Abd… - ACS …, 2023 - ACS Publications
Doxorubicin (DOX) is a cornerstone chemotherapeutic agent for the treatment of several
malignancies such as breast cancer; however, its activity is ameliorated by the development …